Evaluation of FGFR3 As a Therapeutic Target in Head and Neck Squamous Cell Carcinoma

Anne von Mässenhausen,Mario Deng,Hannah Billig,Angela Queisser,Wenzel Vogel,Glen Kristiansen,Andreas Schröck,Friedrich Bootz,Friederike Göke,Alina Franzen,Lynn Heasley,Jutta Kirfel,Johannes Brägelmann,Sven Perner

Targeted oncology（2016）

引用 12|浏览30

暂无评分

摘要

Although head and neck squamous cell carcinoma (HNSCC) is the sixth most common tumour entity worldwide, it remains a clinical challenge. Large-scale explorative genomic projects have identified several genes as potential targets for therapy, including fibroblast growth factor receptor 3 (FGFR3).

查看译文

关键词

HSC3 Cell,FGFR3 Mutation,FGFR3 Expression,Human Papilloma Virus Status,Thiazolyl Blue Tetrazolium Bromide

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要